A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.
"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
Our Standards: The Thomson Reuters Trust Principles.
May 03, 2021 at 01:47PM
https://ift.tt/2SqpdZz
Pfizer in talks with India over expedited approval for COVID-19 vaccine - Reuters India
https://ift.tt/3d5QSDO
No comments:
Post a Comment